All the news Showing 10 of 43 articles from: Activism and civil societyGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Behind Battle Over Drug Prices, Quiet Money From Big Pharma Bloomberg / 19 September 2016 How three drug users took on the might of the Russian state The Guardian / 15 September 2016 Ghana must up its game to win the race against hepatitis The Conversation / 06 September 2016 A boring killer? Addaction / 14 June 2016 Patient associations: a key catalyst for hepatitis advocacy and impact BioMed Central blogs / 01 June 2016 Outside the biomedical box of hepatitis C research BioMed Central blogs / 17 May 2016 Let’s not forget ‘prevention as prevention’ BioMed Central blogs / 14 April 2016 The task now is identifying people who don’t know they’re infected and connecting them to care BioMed Central blogs / 14 April 2016 Lawsuits claim insurers unfairly refuse pricey hepatitis C drugs Seattle Times / 03 February 2016 Harnessing patient power to effect change BMC Blog Network / 28 January 2016 ← Prev12345Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Access to medicines & diagnostics Hepatitis C elimination Models of care Finance, funding & health economics National policy European policy International policy Activism and civil society Pharmaceutical industry Social issues Conference news Email bulletin archive